Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Kennis over compensatiestrategieën bij loopproblemen Parkinson beperkt
sep 2021 | Bewegingsstoornissen